8-KFiled Aug 4, 8:00 PM ET

Destination XL Group Moves to Nasdaq Capital Market; Given Bid-Price Extension

$DXLG · DESTINATION XL GROUP, INC.

Research Summary

AI-generated summary of this SEC filing

Updated

Destination XL Group Moves to Nasdaq Capital Market; Given Bid-Price Extension

What Happened Destination XL Group, Inc. (DXLG) filed an 8-K reporting that Nasdaq notified the company on Feb 4, 2026 that it was not meeting the $1.00 minimum bid-price requirement. After applying on June 30, 2026 to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, Nasdaq approved the transfer on Aug 4, 2026; the listing move will be effective at the open of business on Aug 7, 2026 and the ticker will remain “DXLG.” Following the transfer, Nasdaq granted an additional 180-calendar-day compliance period through Feb 1, 2027 to regain the $1.00 closing bid-price requirement.

Key Details

  • Initial Nasdaq notice of deficiency received Feb 4, 2026; original 180-day cure period lasted until Aug 3, 2026.
  • Company applied to transfer markets on June 30, 2026; transfer approved Aug 4, 2026 and effective Aug 7, 2026.
  • New compliance deadline: Feb 1, 2027 (additional 180 days). To cure, DXLG must have a closing bid ≥ $1.00 for at least 10 consecutive business days during the extension.
  • The company may consider a reverse stock split to regain compliance; any reverse split must be completed at least 10 business days before the Feb 1, 2027 expiration. Failure to regain compliance could lead to delisting and potential appeal to a Nasdaq Hearings Panel.

Why It Matters The company’s listing will remain on Nasdaq (now on the Capital Market tier), preserving public trading under DXLG while it works to fix the low share-price issue. Investors should note the material risk: if the company cannot meet the $1.00 threshold by Feb 1, 2027 (or follow the terms of the extension), Nasdaq could delist the stock. A reverse stock split—likely the most definitive cure—would raise the per-share price but reduce the number of outstanding shares, which can affect share liquidity and investor holdings. The company is monitoring its bid price and evaluating options, per the filing.